People are going to great lengths to get their hands on Ozempic and other semaglutide weight-loos drugs — but the brand-name manufacturer is trying to clamp down.
major player in the pharmaceutical world, Novo Nordisk is also the force behind a significant
legal push to prevent semaglutide knockoffs in the U.S. They created a fan base desperate for their medication. Now, they have to get people to only buy it from them. First released in 2018, semaglutide is a medication that mimics the GLP-1 hormone, regulating the body’s sugar levels, and decreasing the appetite. While the drug was developed and originally approved for diabetes patients, its side-effect of appetite suppression quickly made it a desirable option for weight loss. By early 2023, thecraze was born — with the drug becoming an award show punch line, constant tabloid rumor, and difficult to get even for actual diabetes patients.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal ThoughtsEuropean drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports
Read more »
Apple May Not Like It, but ‘Zapple Pay’ Finds Workaround for Bitcoin Tipping on DamusA new third-party payment service created by benthecarman and futurepaul called Zapple Pay, uses emojis to send zaps on posts. It’s compatible with any Nostr app including damusapp. FrederickMunawa reports
Read more »
EU Investigating Ozempic After Suicidal Thoughts ReportedDrugmaker Novo Nordisk will have its weight-loss drugs, including Ozempic, Saxenda and Wegovy, investigated after Iceland’s health regulator flagged three cases of patients reporting suicidal thoughts.
Read more »
Ozempic diabetes and weight loss medication under investigation after a few reports of suicidal thoughtsThe popular medications Ozempic and Saxenda from Novo Nordisk are being investigated after three people experienced an increase in thoughts of suicide and self-harm.
Read more »
Ozempic being investigated for link to suicidal thoughtsEuropean drug safety regulators are investigating whether Ozempic and other popular diabetes and weight loss medications are linked to increases in suicidal thoughts in patients.
Read more »
E.U. investigates Ozempic, Saxenda after suicidal thoughts reportedThe European Medicines Agency is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients thinking about suicide or self-harm.
Read more »